Oral immunization with recombinant Yersinia enterocolitica expressing a measles virus CD4 T cell epitope protects

Iris Gundel1, Gerald Weidinger1, Volker Ter Meulen1

  • 1Institut für Virologie und Immunbiologie, Versbacher Str. 7, 97078 Würzburg, Germany.

Insights

Oral immunization with a modified Yersinia enterocolitica strain expressing a measles virus protein fragment induced a protective T helper type 1 immune response in mice, offering defense against measles virus-induced encephalitis.

Area of Science:

  • Immunology
  • Virology
  • Microbial Genetics

Background:

  • Measles virus (MeV) causes severe encephalitis, a significant global health concern.
  • Current MeV vaccines are effective but require parenteral administration.
  • Developing alternative, orally deliverable vaccines is a key research objective.

Purpose of the Study:

  • To evaluate the immunogenicity and protective efficacy of an orally administered, attenuated Yersinia enterocolitica vaccine candidate expressing a fragment of the MeV nucleocapsid protein (NCP).
  • To investigate the type of immune response elicited by this novel vaccine strategy.

Main Methods:

  • Construction of an attenuated Yersinia enterocolitica strain engineered to express a specific fragment (amino acids 79-161) of the MeV NCP using its type III secretion system.
  • Oral immunization of C3H mice with the engineered Yersinia strain.
  • Assessment of the induced immune response, specifically T helper type 1 (Th1) cell activity.
  • Evaluation of protection against subsequent challenge with live measles virus, analyzing time- and dose-dependency.

Main Results:

  • Oral immunization successfully induced a significant T helper type 1 (Th1) immune response in C3H mice.
  • The induced Th1 response conferred a notable degree of protection against measles virus-induced encephalitis.
  • Protection was observed to be dependent on both the dose of the vaccine administered and the time elapsed post-immunization.

Conclusions:

  • An orally delivered, attenuated Yersinia enterocolitica vaccine vector expressing a measles virus NCP fragment is capable of eliciting a protective Th1 immune response.
  • This novel oral immunization strategy shows promise for conferring protection against measles virus encephalitis, warranting further investigation.

Related Concept Videos

Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Vaccinations01:51

Vaccinations

Overview
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Cross-reactivity00:42

Cross-reactivity

Overview
Immunological Memory01:23

Immunological Memory

Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature is...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...